William J. Newell
2021
In 2021, William J. Newell earned a total compensation of $5.6M as Chief Executive Officer at SUTRO BIOPHARMA, a 161% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $393,750 |
|---|---|
| Option Awards | $2,994,000 |
| Salary | $625,000 |
| Stock Awards | $1,583,250 |
| Other | $37,678 |
| Total | $5,633,678 |
Newell received $3M in option awards, accounting for 53% of the total pay in 2021.
Newell also received $393.8K in non-equity incentive plan, $625K in salary, $1.6M in stock awards and $37.7K in other compensation.
Rankings
In 2021, William J. Newell's compensation ranked 2,263rd out of 12,415 executives tracked by ExecPay. In other words, Newell earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,263 out of 12,415 | 82nd |
Division Manufacturing | 883 out of 5,501 | 84th |
Major group Chemicals And Allied Products | 337 out of 2,371 | 86th |
Industry group Drugs | 291 out of 2,092 | 86th |
Industry Biological Products, Except Diagnostic Substances | 91 out of 449 | 80th |
Source: SEC filing on April 22, 2022.
Newell's colleagues
We found four more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2021.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019